Integra LifeSciences Holdings Debt to Equity Ratio 2010-2023 | IART
Current and historical debt to equity ratio values for Integra LifeSciences Holdings (IART) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. Integra LifeSciences Holdings debt/equity for the three months ending December 31, 2023 was 0.94.
| Integra LifeSciences Holdings Debt/Equity Ratio Historical Data | |||
|---|---|---|---|
| Date | Long Term Debt | Shareholder's Equity | Debt to Equity Ratio |
| 2023-12-31 | $2.19B | $1.59B | 1.38 |
| 2023-09-30 | $2.16B | $1.58B | 1.37 |
| 2023-06-30 | $2.09B | $1.68B | 1.24 |
| 2023-03-31 | $2.07B | $1.68B | 1.23 |
| 2022-12-31 | $2.09B | $1.80B | 1.16 |
| 2022-09-30 | $2.08B | $1.72B | 1.21 |
| 2022-06-30 | $2.09B | $1.66B | 1.26 |
| 2022-03-31 | $2.06B | $1.62B | 1.27 |
| 2021-12-31 | $2.10B | $1.69B | 1.25 |
| 2021-09-30 | $2.14B | $1.63B | 1.31 |
| 2021-06-30 | $2.14B | $1.58B | 1.36 |
| 2021-03-31 | $2.21B | $1.53B | 1.45 |
| 2020-12-31 | $2.10B | $1.52B | 1.39 |
| 2020-09-30 | $2.06B | $1.40B | 1.47 |
| 2020-06-30 | $2.04B | $1.35B | 1.51 |
| 2020-03-31 | $2.11B | $1.34B | 1.57 |
| 2019-12-31 | $1.89B | $1.42B | 1.33 |
| 2019-09-30 | $1.96B | $1.39B | 1.42 |
| 2019-06-30 | $1.87B | $1.42B | 1.32 |
| 2019-03-31 | $1.81B | $1.40B | 1.30 |
| 2018-12-31 | $1.73B | $1.38B | 1.26 |
| 2018-09-30 | $1.81B | $1.37B | 1.33 |
| 2018-06-30 | $1.84B | $1.34B | 1.37 |
| 2018-03-31 | $2.25B | $1.00B | 2.25 |
| 2017-12-31 | $2.25B | $0.96B | 2.34 |
| 2017-09-30 | $1.51B | $0.91B | 1.65 |
| 2017-06-30 | $1.21B | $0.90B | 1.35 |
| 2017-03-31 | $1.20B | $0.85B | 1.40 |
| 2016-12-31 | $0.97B | $0.84B | 1.15 |
| 2016-09-30 | $1.00B | $0.82B | 1.22 |
| 2016-06-30 | $1.02B | $0.80B | 1.28 |
| 2016-03-31 | $1.05B | $0.78B | 1.36 |
| 2015-12-31 | $1.02B | $0.75B | 1.36 |
| 2015-09-30 | $1.10B | $0.73B | 1.50 |
| 2015-06-30 | $0.93B | $0.71B | 1.30 |
| 2015-03-31 | $0.86B | $0.69B | 1.25 |
| 2014-12-31 | $0.88B | $0.70B | 1.25 |
| 2014-09-30 | $0.86B | $0.69B | 1.25 |
| 2014-06-30 | $0.87B | $0.69B | 1.27 |
| 2014-03-31 | $0.88B | $0.68B | 1.29 |
| 2013-12-31 | $0.53B | $0.67B | 0.79 |
| 2013-09-30 | $0.69B | $0.50B | 1.37 |
| 2013-06-30 | $0.67B | $0.52B | 1.30 |
| 2013-03-31 | $0.65B | $0.51B | 1.27 |
| 2012-12-31 | $0.65B | $0.52B | 1.25 |
| 2012-09-30 | $0.66B | $0.53B | 1.25 |
| 2012-06-30 | $0.66B | $0.51B | 1.29 |
| 2012-03-31 | $0.65B | $0.51B | 1.28 |
| 2011-12-31 | $0.65B | $0.49B | 1.32 |
| 2011-09-30 | $0.67B | $0.50B | 1.34 |
| 2011-06-30 | $0.64B | $0.52B | 1.22 |
| 2011-03-31 | $0.48B | $0.53B | 0.91 |
| 2010-12-31 | $0.52B | $0.50B | 1.04 |
| 2010-09-30 | $0.49B | $0.47B | 1.04 |
| 2010-06-30 | $0.48B | $0.46B | 1.05 |
| 2010-03-31 | $0.48B | $0.46B | 1.05 |
| 2009-12-31 | $0.50B | $0.45B | 1.11 |
| 2009-09-30 | $0.54B | $0.43B | 1.26 |
| 2009-06-30 | $0.54B | $0.40B | 1.35 |
| 2009-03-31 | $0.62B | $0.37B | 1.66 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $2.486B | $1.542B |
| Integra LifeSciences is one of the world leaders in regenerative medicine. The company develops, manufactures and markets cost-effective surgical implants and medical instruments. The company now manufactures and sells products in the following two global reportable business segments: Codman Specialty Surgical (CSS) and Orthopedics and Tissue Technologies (OTT). The CSS business offers global, market-leading technologies, brands and instrumentation. The global commercial network includes clinical specialists, a large direct global sales force and strategic partnerships and distributors that serve hospitals, integrated health networks, group purchasing organizations, clinicians, surgery centers and health care providers in North America, South America, Europe, Asia Pacific, Middle East and Africa. The Tissue Technologies segment includes wound reconstruction and repair products, bone grafts and nerve and tendon repair products. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $206.706B | 25.14 |
| Intuitive Surgical (ISRG) | United States | $132.078B | 79.62 |
| Edwards Lifesciences (EW) | United States | $52.037B | 34.44 |
| DexCom (DXCM) | United States | $51.775B | 88.94 |
| IQVIA Holdings (IQV) | United States | $41.231B | 24.45 |
| IDEXX Laboratories (IDXX) | United States | $39.682B | 47.45 |
| Alcon (ALC) | Switzerland | $38.694B | 28.53 |
| STERIS (STE) | Ireland | $19.843B | 23.49 |
| Hologic (HOLX) | United States | $17.628B | 19.46 |
| Waters (WAT) | United States | $17.451B | 25.04 |
| SONOVA HOLDING (SONVY) | Switzerland | $16.168B | 0.00 |
| ShockWave Medical (SWAV) | United States | $12.248B | 84.63 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $11.379B | 14.05 |
| Sysmex ADR (SSMXY) | Japan | $9.881B | 30.99 |
| Teleflex (TFX) | United States | $9.768B | 15.34 |
| Penumbra (PEN) | United States | $7.812B | 96.57 |
| Masimo (MASI) | United States | $7.192B | 40.33 |
| Globus Medical (GMED) | United States | $6.870B | 21.78 |
| Glaukos (GKOS) | United States | $4.774B | 0.00 |
| Integer Holdings (ITGR) | United States | $3.948B | 25.23 |
| TransMedics (TMDX) | United States | $2.854B | 0.00 |
| LivaNova (LIVN) | United Kingdom | $2.847B | 18.78 |
| PROCEPT BioRobotics (PRCT) | United States | $2.603B | 0.00 |
| Elekta AB (EKTAY) | Sweden | $2.599B | 17.83 |
| Nihon Kohden (NHNKY) | Japan | $2.315B | 19.58 |
| Inari Medical (NARI) | United States | $2.240B | 386.40 |
| Tandem Diabetes Care (TNDM) | United States | $1.997B | 0.00 |
| RxSight (RXST) | United States | $1.914B | 0.00 |
| Alphatec Holdings (ATEC) | United States | $1.703B | 0.00 |
| Veracyte (VCYT) | United States | $1.441B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.864B | 15.98 |
| OPKO Health (OPK) | United States | $0.857B | 0.00 |
| Artivion (AORT) | United States | $0.833B | 96.24 |
| Paragon 28 (FNA) | United States | $0.800B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.701B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.696B | 0.00 |
| Silk Road Medical (SILK) | United States | $0.682B | 0.00 |
| SiBone (SIBN) | United States | $0.628B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.537B | 18.25 |
| IRadimed (IRMD) | United States | $0.511B | 29.68 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.487B | 0.00 |
| Nevro (NVRO) | United States | $0.452B | 0.00 |
| Pulse Biosciences (PLSE) | United States | $0.406B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.391B | 0.00 |
| NeuroPace (NPCE) | United States | $0.368B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.336B | 11.31 |
| CVRx (CVRX) | United States | $0.330B | 0.00 |
| AxoGen (AXGN) | United States | $0.286B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.265B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.260B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.245B | 0.00 |
| Accuray (ARAY) | United States | $0.219B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.185B | 0.00 |
| 908 Devices (MASS) | United States | $0.184B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.179B | 9.64 |
| Atossa Genetics (ATOS) | United States | $0.178B | 0.00 |
| Inogen (INGN) | United States | $0.165B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.146B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.119B | 0.00 |
| Neuronetics (STIM) | United States | $0.115B | 0.00 |
| Yubo Biotech (YBGJ) | China | $0.112B | 0.00 |
| Envoy Medical (COCH) | United States | $0.100B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.094B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.090B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.071B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.064B | 0.00 |
| Hyperfine (HYPR) | United States | $0.058B | 0.00 |
| Vasomedical (VASO) | United States | $0.056B | 9.99 |
| Autonomix Medical (AMIX) | United States | $0.054B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.053B | 108.33 |
| InspireMD (NSPR) | Israel | $0.050B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.049B | 0.00 |
| SEP Acquisition (SEPA) | United States | $0.049B | 0.00 |
| Aspira Women's Health (AWH) | United States | $0.044B | 0.00 |
| ReWalk Robotics (LFWD) | Israel | $0.042B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.039B | 0.00 |
| Pixie Dust Technologies (PXDT) | Japan | $0.037B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.037B | 0.00 |
| LENSAR (LNSR) | United States | $0.036B | 0.00 |
| DarioHealth (DRIO) | United States | $0.034B | 0.00 |
| Precision Optics (POCI) | United States | $0.033B | 0.00 |
| Spectral AI (MDAI) | United States | $0.033B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.023B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.022B | 0.00 |
| PAVmed (PAVM) | United States | $0.018B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.017B | 0.00 |
| Accelerate Diagnostics (AXDX) | United States | $0.017B | 0.00 |
| T2 Biosystems (TTOO) | United States | $0.016B | 0.00 |
| QT Imaging Holdings (QTI) | United States | $0.016B | 0.00 |
| NexGel (NXGL) | United States | $0.014B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.013B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.013B | 0.00 |
| Avinger (AVGR) | United States | $0.006B | 0.00 |
| Venus Concept (VERO) | Canada | $0.005B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.005B | 0.00 |
| Tenon Medical (TNON) | United States | $0.003B | 0.00 |
| Dynatronics (DYNT) | United States | $0.003B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.003B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.002B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.002B | 0.00 |
| Nuwellis (NUWE) | United States | $0.002B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.001B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.001B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |